Recently, it was showed that MSC-derived exosomes with miR-100 cargo could modulate mTOR/HIF-1α signaling axis in recipient breast cancer cells, resulting in a decrease in VEGF expression [109]. The gene discussed is HIF1A; the disease is breast cancer.